Companies House true 2023-12-01 2024-11-30 false 13727775 uk-bus:Director1 2023-12-01 2024-11-30 13727775 uk-bus:Director2 2023-12-01 2024-11-30 13727775 2023-12-01 2024-11-30 13727775 2024-11-30 13727775 uk-bus:EntityHasNeverTraded 2023-12-01 2024-11-30 13727775 uk-bus:FRS102 2023-12-01 2024-11-30 13727775 uk-bus:FullAccounts 2023-12-01 2024-11-30 13727775 uk-bus:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 13727775 2023-11-30 13727775 uk-bus:OrdinaryShareClass1 2023-12-01 2024-11-30 13727775 uk-bus:OrdinaryShareClass2 2023-12-01 2024-11-30 13727775 uk-bus:OrdinaryShareClass3 2023-12-01 2024-11-30 13727775 uk-bus:PreferenceShareClass1 2023-12-01 2024-11-30 13727775 uk-bus:PreferenceShareClass2 2023-12-01 2024-11-30 13727775 uk-bus:PreferenceShareClass3 2023-12-01 2024-11-30 13727775 uk-core:ShareCapitalPreferenceShares 2024-11-30 13727775 uk-core:ShareCapitalPreferenceShares 2023-11-30 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 13727775

NETHERLANDS NEW HELEEKEN BIOLOGICAL ENGINEERING GROUP CO., LTD.

Dormant Accounts

30 November 2024

NETHERLANDS NEW HELEEKEN BIOLOGICAL ENGINEERING GROUP CO., LTD. Registered Number 13727775

Balance Sheet as at 30 November 2024

2024 2023
£ £
Called up share capital not paid
60000
60000
Net assets
60000
60000
Issued share capital
60000 Ordinary Shares of £ 1 each 60000 60000
Total Shareholder funds
60000
60000

STATEMENTS

  1. For the year ending 30 November 2024 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 16 January 2025

And signed on their behalf by:
Quanjun XING, Director